Business Context and Reporting Period
Company: Icecure Medical Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Filing Date: September 23, 2021
Reporting Period: First Half of 2021 (H1 2021)
This filing serves as a conduit for a press release issued on September 23, 2021, titled "IceCure Medical Reports Financial Results for the First Half of 2021 and Recent Operating Highlights." The document itself does not contain the detailed financial tables or narrative; it references the press release as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet and does not contain specific numerical data. Consequently, the following metrics are not available in this source text:
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not provide specific comparative data or material changes versus the prior period. It only indicates that such results were reported in the referenced press release.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies. These items are expected to be detailed in the attached press release (Exhibit 99.1), which is not included in the input content.
Investor Verification Checklist
- Review the full text of the press release (Exhibit 99.1) to obtain actual H1 2021 financial figures.
- Verify the specific "Recent Operating Highlights" mentioned in the press release title.
- Check for any updated guidance or clinical trial milestones discussed in the full press release.
- Confirm the company's cash position and burn rate from the detailed financial statements referenced in the press release.